Department of Psychology, Queens College, City University of New York (CUNY), Flushing, NY, USA.
Clin Exp Allergy. 2012 Dec;42(12):1765-71. doi: 10.1111/j.1365-2222.2012.04042.x.
Previous studies have suggested an association between allergy and mood and anxiety disorders. Yet, extant work suffers from methodological limitations.
To investigate the association between physician-diagnosed allergy and DSM-IV mood and anxiety disorders in the general population, and to examine the role of allergy treatment in this relationship.
Data were drawn from the German National Health Interview and Examination Survey, a population-based, representative sample of 4,181 adults aged 18-65 in Germany. Allergy was diagnosed by physicians during medical examination and mental disorders were diagnosed using the CIDI.
Allergy was associated with an increased prevalence of any anxiety disorder [OR = 1.3 (1.1, 1.6)], panic attacks [OR = 1.6 (1.1, 2.1)], panic disorder [OR = 1.6 (1.01, 2.3)], GAD [OR = 1.8 (1.1, 3.0)], any mood disorder [OR = 1.4 (1.1, 1.7)], depression [OR = 1.4 (1.1, 1.7)] and bipolar disorder [OR = 2.0, (1.0, 3.8)]. After adjusting for desensitization treatment status, these relationships were no longer significant. Those treated for allergy were significantly less likely to have any mood or anxiety disorder [OR = 0.65 (0.4, 0.96)], compared to those untreated. All relationships were adjusted for age, gender and socioeconomic status (SES).
CONCLUSIONS & CLINICAL RELEVANCE: These findings provide the first evidence of a link between physician-diagnosed allergy and DSM-IV mood and anxiety disorders in a representative sample. Treatment for allergy may mitigate much of this relationship.
先前的研究表明过敏与情绪和焦虑障碍之间存在关联。然而,现有研究存在方法学上的局限性。
在普通人群中调查医师诊断的过敏与 DSM-IV 情绪和焦虑障碍之间的关联,并研究过敏治疗在这种关系中的作用。
数据来自德国国家健康访谈和体检调查,这是一项基于人群的,代表德国 4181 名 18-65 岁成年人的样本。过敏由医生在体检时诊断,精神障碍则使用 CIDI 进行诊断。
过敏与任何焦虑障碍的患病率增加有关[OR = 1.3(1.1,1.6)]、惊恐发作[OR = 1.6(1.1,2.1)]、惊恐障碍[OR = 1.6(1.01,2.3)]、广泛性焦虑障碍[OR = 1.8(1.1,3.0)]、任何情绪障碍[OR = 1.4(1.1,1.7)]、抑郁症[OR = 1.4(1.1,1.7)]和双相情感障碍[OR = 2.0(1.0,3.8)]。调整脱敏治疗状况后,这些关系不再显著。与未接受治疗的患者相比,接受过敏治疗的患者患任何情绪或焦虑障碍的可能性显著降低[OR = 0.65(0.4,0.96)]。所有关系均调整了年龄、性别和社会经济地位(SES)。
这些发现提供了在代表性样本中,医师诊断的过敏与 DSM-IV 情绪和焦虑障碍之间存在关联的首个证据。过敏治疗可能减轻了这种关系的大部分影响。